Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis.

Johannes Roesch,Michael Oertel,Simone Wegen,Maike Trommer, Julia Schleifenbaum,Dominik Hering,Matthias Mäurer,Stefan Knippen,Sophie Dobiasch,Maria Waltenberger,Jens von der Grün,Daniel Medenwald, Christoph Süß, Michael Hoeck,Lukas Käsmann,Daniel F Fleischmann,Alexander Rühle,Nils H Nicolay,Alexander Fabian,Anastassia Löser, Sebastian Heß,Bálint Tamaskovics, Maria Vinsensia,Markus Hecht

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology（2022）

引用 9|浏览8

暂无评分

摘要

Re-irradiation of locally recurrent or second primary HNSCC is efficient, especially if doses above 50Gy (EQD2) are delivered. ECOG performance score was the strongest prognostic parameter for OS and PFS.

查看译文

关键词

HNSCC,Re-Radiochemotherapy,Re-irradiation,head and neck cancer,recurrent,reirradiation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要